Introduction
The importance of transcriptional repression in the regulation of gene expression in bacteria, was recognized almost 40 years ago by Jacob and Monod and since then has been established as a major mechanism in transcriptional regulation. Transcriptional repressor proteins aect their target genes through direct or indirect DNA-binding at the regulatory regions of the gene of interest and repress transcription by a variety of distinct mechanisms (for recent reviews see Knoep¯er and Eisenman 1999; Bird and Wole 1999; Maldonado et al., 1999) . A repressor protein can inhibit transcription of selective genes by (i) displacing an activator from the DNA, and (ii) masking/blocking the activation domain of a transcriptional activator. In addition a repressor protein can actively inhibit transcription, independently of transcriptional activators by (i) aecting chromatin structure and DNAaccessibility at the region of the gene of interest and (ii) directly interfering with the basic transcriptional machinery. There is evidence to suggest that ETSdomain proteins may include paradigms for each of these categories.
ETS domain encoding genes, the prototype of which is the v-ets oncogene of avian leukemia virus E26 (Nunn et al., 1983; Leprince et al., 1983) are present in all the multicellular organisms analysed so far (Lautenberger et al., 1992; Degnan et al., 1993; Laudet et al., 1999) The identi®cation of v-ets related genes in the last 15 years has established the ETS family as one of the largest families of transcriptional regulators, with diverse functions and activities (for recent reviews see: Ghysdael and Boureux, 1997; Dittmer and Nordheim, 1998; Ghosh and Kolodkin, 1998) . ETS proteins are characterized by a conserved DNA-binding domain (ETS domain) which binds DNA sequences centered over a GGAA/T core motif (EBS: ETS binding site, Karim et al., 1990) and have been shown to mediate cellular proliferation, dierentiation and tumorigenesis (for reviews see Watson et al., 1990; Seth et al., 1992; Macleod et al., 1992; Wasylyk et al., 1993; Ghysdael and Boureux, 1997; Dittmer and Nordheim, 1998; Ghosh and Kolodkin, 1998) . Most of the known ETS proteins have been shown to activate transcription, however in the last few years an increasing number of transcriptional repressors has been identi®ed (O'Neill et al., 1994; Sgouras et al., 1995; Maira et al., 1996; Lopez et al., 1999; Chakrabarti and Nucifora, 1999) Furthermore, a number of ETS proteins have been suggested to activate or repress transcription in a context speci®c manner (Zinck at al., 1993; Borras et al., 1995; Sieweke et al., 1996; Foos et al., 1998; Xing et al., 2000; Li et al., 2000) .
Our current knowledge on ETS proteins indicates that at any given time multiple members of this family exist in any given cell, all of which can recognize similar, and many of them identical EBS response elements. The function and speci®city of ETS proteins is controlled at several levels. First, the expression of several ETS genes is either highly tissue-speci®c or regulated in response to speci®c extracellular signals (for review see: Ghysdael and Boureux, 1997; Wasylyk and Nordheim 1997) . Second, speci®c intracellular signaling pathways have been shown to directly impinge upon the activity of particular ETS protein by regulating their subcellular compartmentalization (Le Gallic et al., 1999; Ducret et al., 1999) , their DNAbinding activity (Rabault and Ghysdael, 1994; Martin et al., 1996; Cowley and Graves, 2000) or their transactivation potential (Marais et al., 1993; O'Hagen et al., 1996; McCarthy et al., 1997) . Finally, regulation Oncogene (2000) 19, 6524 ± 6532 ã 2000 Macmillan Publishers Ltd All rights reserved 0950 ± 9232/00 $15.00 www.nature.com/onc *Correspondence: G Mavrothalassitis of many promoters/enhancers by ETS proteins often critically depend upon their interaction with unrelated transcription factors on composite DNA elements (Dalton and Treisman, 1992; Janknecht et al., 1993; Treisman, 1994; Giese et al., 1995; Wolberger, 1998; Goetze et al., 2000) . These and other mechanism are presumed to accommodate the multitude of ETSdomain proteins in a cell without apparent con¯icts. However, it would be dicult to envision today a strict gene expression regulation without the presence of transcriptional repressors that ensure transcription blockade of a given gene. To that extent ETS proteins with transcriptional repressor activity may be vital to our understanding of the orchestrated presence and the role of ETS-domain proteins in transcriptional regulation. This review is focusing on ETS genes that exhibit transcriptional repressor activity (Figure 1 ) and their possible role in speci®c biological processes.
YAN
The ®rst ETS domain protein identi®ed, initially as a suppressor (Lai and Rubin, 1992) and later as a transcriptional repressor (O'Neill et al., 1994) was the Drosophila gene yan/aop. yan was originally identi®ed in an RTK signaling screening as a negative regulator of R7 photoreceptor neuron dierentiation in the Drosophila developing eye. Later studies have shown that yan can act as an inhibitor of dierentiation in multiple developmental processes, preventing neuronal and nonneuronal cell types from responding inappropriately to external signals (Rebay and Rubin, 1995) . yan has been shown to be downstream of, and negatively regulate the Sevenless, the EGF-receptor and the FGF-receptor pathways. It is believed to be involved in the regulation of the transition between undierentiated and dierentiated cells as a result of extracellular signals. In the Drosophila developing eye yan is expressed in all undierentiated cells and is down regulated as cells dierentiate. This pattern of expression is also observed in ventral neuroectoderm development and in other stages during development. Hypomorphic yan mutants exhibit an increased number of R7 photoreceptor cells as a result of Sev/ Ras1 signaling, whereas activated yan mutants inhibit neuronal and mesoderm dierentiation (Rebay and Rubin, 1995; Lai et al., 1997) . However, other studies utilizing a null yan mutation indicate that the primary role of yan may be to inhibit cells from entering the cell cycle in the absence of the appropriate signal (Rogge et al., 1995) . This would be consistent with the hyperproliferative phenotype observed in yan/aop mutants. This is also consistent with the increase in apoptosis induced by activated yan at the morphogenetic furrow of the eye disk when a cell receives a proliferation signal while entry into G1 is blocked by the activated yan. A role of yan in proliferation rather than dierentiation is further supported by the identi®cation of a master key gene in eye development (Halder et al., 1995a,b) although regulation of this gene by yan cannot be excluded (Rebay et al., 2000) .
Most members of the RTK signaling pathways are highly conserved through evolution from the receptors to the MAPKs (for a comprehensive review see Lewis et al., 1998) . Yan is highly conserved in structure, function, expression pattern and regulation between two Drosophila sibling species arguing for its important role (Price and Lai, 1999) . However, transcription factors exhibit considerable diversity throughout evolution that increases with genome expansion, and to that extent it may not be surprising that no yan orthologues have been identi®ed in vertebrates. The closest YAN homologue in vertebrates is TEL (Golub et al., 1994) , an ETS-domain protein that also exhibits transcriptional repressor activity (see below).
In transient transfection assays, YAN can antagonize the activity of the Pointed-P2, a transactivator of the ETS family (O'Neil et al., 1994; Treier et al., 1995) . Genetically, YAN antagonizes Pointed proteins and DJun activities in several developmental pathways in response to the activation of the ERK or JNK protein kinases (O'Neil et al. 1994; Riesgo-Escovar et al. 1994; Treier et al., 1995) . However, no bona ®de YAN target genes have been identi®ed so far, and no information is available on the YAN repression domain and the possible mechanisms by which it represses transcription. In the absence of extracellular signals YAN is nuclear and presumably represses transcription of its target genes. Upon RTK activation, YAN has been proposed to be phosphorylated by MAPK and degraded probably in the cytoplasm (Rebay and Rubin, 1995) , thus allowing the activation of YANregulated genes by other ETS-domain transcription factors, like the Drosophila Pointed (Scholz et al., 1993; Klambt, 1993) . This provides a model where upon receptor stimulation, a binary system of ETS-domain proteins, one of which is inhibited the other is activated by the same signal, switch the transcription on a given gene from the repressed state to the activated state. Such a system would insure the strict and concerted control of YAN/Pointed target genes, consistent with the severity of the yan and pointed phenotypes in Drosophila. De®nitive assessment of this model requires the identi®cation of YAN/Pointed-regulated genes. The completed sequencing of the entire Drosophila genome, in combination with the rapidly developing DNA-array technology should provide valuable answers both on the possible interplay of Yan and Pointed on speci®c promoters, as well as some insights on the role of these genes in cellular proliferation and dierentiation. ERF ERF (ETS2 Repressor Factor) is a ubiquitously expressed member of the ETS gene family. Besides the conserved ets-DNA-binding domain (Sgouras et al., 1995) , ERF presents no other homology with other ETS proteins, except PE-1 (Klemsz et al., 1994) with which they form a new subclass of ETS proteins. ERF is a strong transcriptional repressor and represses transcription via a distinct domain at the carboxylterminus of the protein, that can not be found in PE-1. This domain has no recognizable pattern suggestive of its mode of action and the molecular mechanisms involved in ERF-mediated repression are unknown. However, there is a report indicating that ERF mediated repression may not involve the Sin3/NcoR system (Heinzel et al., 1997) . The ERF repression domain has been transferred to a number of other DNA binding domains and transcription factors (GAL4, ETS1, FLI1, c-MYC, NFkB) resulting an array of transcriptional repressors with diverse speci®city and functions (Sgouras et al., 1995; Athanasiou et al., 2000; and G Mavrothalassitis, unpublished observations) . A multitude of native and arti®cial promoters have been shown to be repressed by ERF in a DNA-binding-dependent manner. The Prolactin gene promoter in particular, appears to be regulated by ERF in a biological relevant way (Day et al., 1998) . However, since these experiments made use of transient transfection assays, it remains to be seen to what extent these genes are actual ERF targets in vivo.
Like yan, ERF is downstream of the RAS/ERK signaling pathway and is directly regulated by ERK via phosphorylation. ERK physically associates with, and phosphorylates ERF at multiple sites both in vitro and in vivo. Phosphorylation by ERK results in the rapid export of ERF from the nucleus. Unlike YAN, the protein is stable in the cytoplasm and reaccumulates in the nucleus upon ERK inactivation (Le Gallic et al., 1999) . ERF cellular localization is exclusively dependent on export rates with the import being unaected by the phosphorylation state of the protein. Nuclear export is Leptomycin B-sensitive suggesting the involvement of the Exportin/RanGTP-dependent pathway, though ERF does not possess an identi®able nuclear export signal (NES). Domain mapping indicates that at least two regions of the protein are required for nuclear export, consistent with the extended phosphorylation mediating ERF export (G Mavrothalassitis, unpublished observations). It is not clear if subcellular localization is the only function of ERF regulated by ERK phosphorylation. Mutation of an ERK phosphorylation site within the ERF repression domain to Glutamic acid, to mimic the phosphorylated state of the protein, decreases the repressor activity (Sgouras et al., 1995) . This decrease can not be attributed to DNA binding or nuclear accumulation suggesting additional regulation at the repression level. However, this hypothesis should be further evaluated in the context of the ERF repression mechanism.
ERF can suppress oncogenic transformation of NIH3T3 cells by several oncogenes. Wild type ERF can suppress E26-induced transformation (Sgouras et al., 1995) . The transforming potential of the Gag-MybEts oncoprotein of the E26 virus both in this system and in hematopoietic progenitors has been shown to depend on the v-ets DNA-binding domain (Yuan et al., 1989; Rossi et al., 1996) , suggesting that common or cooperating pathways and/or targets may be controlled by the two proteins. Thus a binary system similar to the yan/pointed may also be in place in vertebrates where ERF would be the yan analogue while the pointed role should be attributed to one of the members of the ETS1 sub-family of ETS genes. Transforming members of the ETS family regulated by RAS/ERK signaling would also appear as appropriate partners for ERF, however, this hypothesis needs to be con®rmed.
Mutants of ERF that have the MAPK phosphorylation sites mutated to Alanine are insensitive to ERK phosphorylation and constitutively nuclear. These mutants can block RAS-induced transformation of NIH3T3 cells in contrast to wt ERF. This would provide some genetic con®rmation for the role of ERF within the RAS-signaling pathway. Expression of the same mutants in normal cells induces a block in the G1 phase of the cell cycle, while overexpression of the wt ERF has minimal eect on cell cycle progression. This is consistent with the nuclear localization of ERF in G0/G1 arrested cells and its immediate nuclear export upon mitogenic stimulation, suggesting that ERF may be controlling RAS-responsive genes required for cell cycle re-entry or progression (Le Gallic et al., 1999) . The ubiquitous expression of ERF suggests that components of the cell cycle machinery may be under the transcriptional repression of ERF. This would provide a direct link between RAS signaling and the cell cycle machinery. Indeed, cell cycle arrest induced by constitutively active mutants of ERF can be alleviated by the overexpression of speci®c Cyclins or loss of the Retinoblastoma protein (G Mavrothalassitis unpublished observations), lending further support for this model. However, loss of function mutation and identi®cation of candidate target genes are required to evaluate such a possibility.
NET NET/SAP-2/ERP (Giovane et al., 1994; Lopez et al., 1994; Price et al., 1995) is a member of the TCF subfamily of ETS-domain proteins that are capable to form ternary complex with DNA and the Serum Response Factor (SRF). Like the other TCFs, NET includes an amino-terminal ETS domain (A domain) harboring the DNA-binding activity, a B domain mediating the TCF ± SRF interaction, and a carboxyterminal C domain that can activate transcription upon phosphorylation by MAPKs. However, this activation appears to be weaker as compared to the C domains of the other TCFs (Price et al., 1995) . Unlike other TCFs, NET exhibits strong transcriptional repressor activity , though preliminary reports from A Sharrock's lab (Univ. of Manchester, UK, personal communication) indicate that ELK1 may also harbor a repression domain distinct of that found in NET. NET has two domains that have been shown capable to suppress transcription when transferred to a heterologous DNA-binding domain, one of which can interact with the CtBP co-repressor (Criqui-Filipe et al., 1999) . This provides a possible mechanism for inhibition by Net, which under proper conformation could interact with CtBP and recruit HDAC on the promoters of its target genes. It is not clear by which mechanism the other NET inhibitory domain may mediate transcriptional repression. Interestingly, upon RAS/ERK activation NET like the other TCFs can also activate transcription, providing a paradigm where a single protein can repress or activate the transcription of a gene depending on extracellular signals (Giovane et al., 1994) . GETS-1a, a TCF isolated from gold®sh, is also capable to repress or activate transcription of a given promoter in a signal-dependent maner (Goldman et al., 1998) . Although it is not known if NET-like factors have the same targets in their basal and induced states, such a hypothesis is not inconceivable.
An additional interesting feature of NET is that it is the only known ETS-domain protein that contains a Leucine-rich nuclear export signal (NES) within the ®rst helix of the ETS DNA-binding domain. This NES is functional when transferred to a heterologous protein and is involved in the export of NET from the nucleus in response to stress activated kinases, in particular JNK B Wasylik, IGMCB, France, personal communication) . It remains to be determined how dierent combinations of the three subclasses of MAPK may aect NET localization and activity. It is not evident if any of the three subclasses may be dominant over the others, and in which in vivo context this regulation may be in eect. Nonetheless, NET may be a paradigm of a transcription factor that (depending on the signaling context) can either repress, or activate or even be neutral in the regulation of its target genes. Thus, NET may regulate expression of a given promoter not only in a qualitative but also in a quantitative way, providing a paradigm for a mode of regulation distinct from the binary model (on ± o) usually suggested for the function of transcription factors.
A NET splicing variant designated NET-b (Giovane et al., 1997) contains only the A and B domains, and only one of the repression domains (NID). This variant can also act as a repressor of transcription. However, NET-b does not contain the C domain and its activity is not regulated by RAS signaling. It is unclear if NETb responds to other signaling pathways and if its distinct carboxyl-terminal region has a functional role. It is also not known if it is regulated by subcellular localization as NET. NET-b can be detected in the cell nucleus, where it can presumably act as repressor of EBS-regulated genes. A third splice variant designated NET-c (Giovane et al., 1997) that also contains domains A, B, NID, but not C, can be identi®ed by PCR and can also act as an inhibitor of transcription. However, it is not clear if this gene product can be identi®ed in cells or is the result of aberrant splicing.
Despite its intriguing regulation and multiple gene products, little is known about the biological role of NET. Similar to other TCFs, NET can form ternary complexes with SRF and convey immediate early transcriptional responses to a number of extracellular stimuli. However, it is not known if the same targets are recognized by NET and the other TCFs. In this model NET may be substituted by other TCFs in a signaling-dependent manner and allow transcriptional activation. Alternatively, NET may be controlling a subset of SRF-responsive genes that are quantitatively regulated in a signal-dependent manner. In support of this hypothesis, there are data suggesting that in the context of the whole protein, NET DNA-binding may be dierent from that of the other TCFs (Price et al., 1995) . In addition, dierent TCFs may have dierent eciency in the formation of ternary complexes (Fitzsimmons et al., 1996) . This would argue that distinct genes are regulated by the dierent TCFs. However, given the ability of all TCFs to form similar complexes and aect the same reporters, it would be reasonable to assume that in a given cell the transcription of speci®c genes may be regulated by TCFs in a signal dependent manner and in a way similar to the one suggested for YAN/Pointed. As with other ETS genes, the analysis of loss of function mutants and the identi®cation of target genes will greatly improve our understanding on the role of this gene and the mechanism of their action.
TEL TEL (also known as ETV-6) is one of the few ETS genes known to be associated with human malignancies, and the only one of them with transcriptional repression activity. It was originally identi®ed by virtue of its rearangement in speci®c cases of chronic myelomonocytic leukemia presenting a t(5,12)(q33;p13) chromosomal translocation (Golub et al., 1994) . Since then, TEL has been shown to be frequently rearranged in a wide variety of leukemia and in solid tumors (see below). TEL, together with the recently identi®ed TEL-B (or TEL-2), a gene encoding a protein closely related to that encoded by TEL, de®nes a new sub-class of the ETS family in mammals (Potter et al., 2000; Poirel et al., 2000) . TEL appears to be ubiquitously expressed in mouse and human tissues whereas TEL-B/TEL-2 expression is more restricted (Golub et al., 1994; Wang et al., 1997 Wang et al., , 1998 Potter et al., 2000; Poirel et al., 2000) . TEL is essential to mouse development as its inactivation by homologous recombination is lethal at day 10.5 ± 11.5 of embryonic development. At that age profound defects are seen in yolk sac angiogenesis, and speci®c areas of apoptotic cell death can be identi®ed in the embryo, suggesting a widespread role of TEL in several developmental processes (Wang et al., 1997) . The analysis of hematopoietic progenitors at various developmental stages in chimeras obtained from mouse blastocysts after transfer TEL7/7 embryonic stem (ES) cells demonstrates an essential postnatal role of TEL in establishing hematopoiesis of all lineages in adult bone marrow (Wang et al., 1998) . In contrast, TEL7/7 ES cells contribute normally to embryonic (yolk-sac derived) and fetal de®nitive (liver-derived) hematopoiesis, indicating a speci®c and non redundant function of TEL in either migration or homing of hematopoietic progenitors to the adult bone marrow micro-environment or in the response of these cells to bone marrow stroma derived signals.
TEL encodes two nuclear polypeptides of 452 (TEL-M1) and 409 (TEL-M43) amino-acids residues, respectively. These two forms arise from alternative translation initiation at two successive AUG initition codons in the TEL mRNA, where TEL-M1 is most abundantly expressed in the vast majority of cell types analysed . The ETS domain of TEL is most highly related to that of TEL-2/TEL-B (85% identity). Compared to the majority of the other ETS domains both TEL and TEL-2/TEL-B present primary amino-acid sequence deviations in the a1 helix, present at the extreme amino-terminus of the ETS domain, and at the end of the a3 recognition helix. Yet, the isolated ETS domain of TEL and TEL-B/TEL-2 binds conventional EBS in vitro (Poirel et al., , 2000 Potter et al., 2000) and regulate EBS-driven transcription (see below). However, in vitro, the DNA binding activity of full-length TEL is considerably lower as compared to that of its isolated ETS domain, suggesting that the DNA binding properties of TEL are subject to an intramolecular repressive mechanism as frequently observed in other ETS proteins (for review, see Ghysdael and Boureux, 1997; Graves and Petersen, 1998) . Besides its conserved ETS domain, TEL and TEL-B/TEL-2 share with a large subgroup of ETS family members another conserved domain known as the B domain (Boulukos et al., 1990) , pointed domain (Klambt, 1993) or NCR domain . The function of this domain in other ETS proteins is not clear, although in some instances it has been shown to modulate the transcriptional activation properties of speci®c members of the family such as ETS-1 or FLI-1 (for review, see Ghysdael and Boureux, 1997) . The structure of the B/pointed domain of ETS-1 has been determined recently by NMR and shown to fold into a ®ve-helix bundle (Slupsky et al., 1998) . ETS-1 is monomeric in solution whereas TEL assemble into oligomers, a property which is exclusively mediated by its B/pointed domain (Jousset et al., 1997) . TEL-B/TEL-2 also self-associates in vitro and in vivo through its B/pointed domain and associates with TEL as well (Potter et al., 2000; Poirel et al., 2000) .
When bound to the EBS of either arti®cial or natural promoters, both TEL-M1 and TEL-M43 isoforms were found to strongly repress promoter activity (Lopez et al., 1999) . Repression of EBS-driven transcription by TEL was found to require an oligomeric protein since monomeric forms of TEL generated either by deletion of the self-association domain or its substitution by the homologous B/pointed domain of monomeric ETS1 failed to repress (Lopez et al., 1999) . TEL is an active repressor as several transportable domains were identi®ed through the study of fusion proteins between various portions of TEL and the DNA binding domain of the S. cerevisiae GAL4 (GALDBD). Two studies converge to demonstrate that the large central domain of TEL (encoded by the large TEL exon 5; Baens et al., 1996) , which extends between the B/pointed domain and the ETS domain includes a repression domain (Lopez et al., 1999; Chakrabarti and Nucifora, 1999) . In these transient assays, the isolated B/pointed domain also scored as a weak repression domain (Chakrabarti and Nucifora, 1999; Fenrick et al., 1999) . Whether this domain eectively functions as repression domain in the context of TEL itself is not clear, because the replacement of the B/pointed domain of TEL by unrelated oligomerization domains, including that of GAL4 or the leucine zipper of the EBV ZEBRA, restores both self-association and repression of EBS-dependent transcription at levels close to the wild type protein (Lopez et al., 1999 ). An additional repression domain was identi®ed which encompasses the ETS domain and the 50 amino-acids immediately upstream of the ETS domain (Lopez et al., 1999) . Although some of the published data are sometimes dicult to reconcile in their details, all converge to indicate that TEL-mediated repression is likely to be dependent upon the recruitment of co-repressors ultimately linked to histone (protein) deacetylases. First, mSin3A was found to associate with both overexpressed TEL and its B/pointed domain fused to GALDBD with Sin3A binding correlating with the repressive properties of this GALDBD fusion protein (Fenrick et al., 1999) . Using in vitro translated proteins or overexpressed TEL, in vivo interactions with SMRT or N-CoR were also observed and increased dosage of either of these co-repressors was found to increase TEL repressive properties (Guidez et al., 2000; Chakrabarti and Nucifora, 1999) . TEL-mediated repression of EBSdriven transcription is clearly dependent upon the recruitment of protein deacetylases since it is strongly inhibited by Trichostatin A (TSA), a deacetylase inhibitor (R Lopez and J Ghysdael, unpublished observations). Whether the interaction of TEL with speci®c co-repressors is regulated or whether distinct repressor complexes are involved in dierent cell lineages or in the regulation of dierent genes remains to be established. Furthermore, there is no evidence that the recruitment of co-repressors/deacetylases complexes is the sole mechanism used by TEL to repress transcription. Finally, given the fact that the activity of TEL is clearly under conformational control, and since ETS proteins have been shown to play architectural role in multiprotein complexes in speci®c promoter/enhancers, it cannot be excluded that TEL could also play a role in transcriptional activation.
Only limited information is available concerning the transcriptional regulatory properties of TEL-B/TEL-2, except that its central domain, although completely unrelated to that of TEL, also functions as transportable repression domain when fused to the GAL4DBD (Poirel et al., 2000) . It would be important to investigate whether this domain is functional in the context of the full-length TEL-B/TEL-2 and whether the repressive properties of TEL-2/TEL-B also depend upon the recruitment of deacetylase or upon a completely dierent mechanism. Since TEL and TEL-B/TEL-2 can form heteromers in vivo this could introduce additional¯exibity in repression mediated by the members of the TEL subfamily.
The Drosophila YAN encodes an ETS protein which is the most closely related to TEL and TEL-B/TEL-2 in both its ETS domain and in its B/pointed domain. As detailed above, activation of the ERK and JNK protein kinases induces the relocalisation of YAN from the nucleus to the cytoplasm, and the mutation of several ERK/JNK consensus phosphorylation sites into Alanine result in a constitutively active (repressive) YAN. TEL is also a phosphoprotein in vivo with the TEL-M1 and TEL-M43 isoforms subject to both common and distinct phosphorylation events R Lopez and J Ghysdael, unpublished observations) . TEL repressive properties can be relieved in response to the activation of as yet uncharacterized signaling pathaways laying downstream of protein tyrosine kinases (R Lopez and J Ghysdael, unpublished observations). Whether this regulation depends upon the modi®cation of TEL phosphorylation is under investigation.
TEL-derived oncoproteins
In man, over a dozen chromosomal translocations involving TEL are associated with leukemia and, more rarely solid tumors (for review, see Rubnitz et al., 1999) . These translocations most often result in the expression of fusion proteins. In one category, chimeric proteins are formed between the amino-terminal domain of TEL, including always its self-association domain, and the catalytic domain of protein tyrosine kinases (PDGFRb, ABL, JAK2, TRK-C). In these chimeric proteins, the B/pointed domain of TEL remains functional, induces self-association and constitutively activates the tyrosine kinase activity of the fused catalytic domains. These properties are central to the transforming properties of these fusion oncoproteins in several cellular models and to their leukemogenic properties in animal models (Carroll et al., 1996; Golub et al., 1996; Jousset et al., 1997; Lacronique et al., 1997; Schwaller et al., 1998; Ritchie et al., 1999; Tomasson et al., 1999; Carron et al., 2000) .
The t(12;22)(p13;q11) translocation found in several cases of myeloid leukemia leads to the expression of a MN1-TEL fusion protein in which the carboxy-terminal part of TEL including the ETS domain is fused to MN1 sequences. Although the biochemical properties of these fusion proteins have not been reported. MN1-TEL would be expected to bind EBS response elements in genes regulated by TEL or other members of the ETS family to deregulate their expression. In that respect, MN1-TEL is similar to the EWS-FLI1/EWS-ERG and TLS-ERG fusion genes expressed as the result of recurrent chromosomal translocations in Ewing sarcomas and leukemias, respectively (for review, see Ghysdael and Boureux, 1997) .
The most frequent chromosomal translocation found in childhood leukemia is the t(12;21)(p13;q22) in B-cell ALL. This translocation results in the fusion of TEL with AML1 to generate a TEL-AML1 fusion protein in which the ®rst 336 amino-acid residues of TEL, including the B/pointed domain and the central repression domain, are fused to all but the ®rst 20 amino-acid residues of AML1 (Golub et al., 1995; Romana et al., 1995a,b) . AML1 (also known as CBFA2) is the human ortholog of the mouse Core Binding Factor (CBF), a transcriptional activator of the Runt family (for review, see Ito and Bae, 1997) . AML1, together with an unrelated CBFb subunit, binds speci®c DNA sequences through its 128 aminoacids runt domain and functions either as transcriptional activator or repressor, depending on the promoter/enhancer tested. The analysis of the activity of TEL-AML1 on model AML1 target genes indicates that TEL-AML1 is a transcriptional repressor (Hiebert et al., 1996; Fears et al., 1997; Uchida et al., 1999; Fenrick et al., 1999) . Whether TEL-induced oligomerization of TEL-AML1 prevents AML1 to interact with its normal co-activators (e.g. p300) is unknown. Both the oligomerization-dependent repression domain of TEL (and/or the B/pointed domain), and a Sin3A binding site localized downstream of the runt domain are involved in TEL-AML1-induced repression (Fenrick et al., 1999; Uchida et al., 1999) . Sin3A binds considerably more stably to TEL-AML1 than to either AML1 or TEL, suggesting that the strong repressive properties of TEL-AML1 depend upon deregulated Sin3A binding (Fenrick et al., 1999) . However, the mechanism involved in TEL-AML1-mediated repression is likely to be more complex. Unlike AML1, TEL-AML1 has been shown to also interact with NcoR through the TEL central repression domain, suggesting that the repressive activity of TEL-AML1 on AML1 target genes involves altered regulation (Guidez et al., 2000) . Of note, most of the studies of TEL-AML1 made use of AML1-regulated promoters/enhancers which are unlikely to be relevant to TEL-AML1 induced leukemia. It remains to be seen to what extent the oncogenic properties of TEL-AML1 depend upon these biochemical properties.
Context speci®c repression
The majority of ETS-domain proteins are believed to be transcriptional activators. However interaction with other proteins can minimize or eliminate their transactivating eect as in the case of ETS1/EAP1 (Li et al., 2000) and ETS1/MAF-B (Sieweke et al., 1996) . This could represent a system where a transcriptional activator can become a repressor via its interaction with cell type speci®c factors. Aberrant expression of ETS genes can suppress tumorigenic phenotypes as in the case of ETS1 (Huang et al., 1997) and ETS2 (Foos et al., 1998) . This suppression may be due to either activation of alternative pathways or to competition of endogenous factors for binding on speci®c target genes. Association of aberrantly expressed ETS genes in these promoters could disrupt multiprotein complexes and inactivate transcription. Overexpression of PEA3 can suppress overexpressed HER-2/neu in breast cancer cells (Xing et al., 2000) although it does not aect normal HER-2/neu expression in other breast cancer cells. Finally, although EWS-FLI1 fusions have been shown to be strong transcriptional activators, they can repress transcripsion of the TGFb-RII gene promoter (Hahm et al., 1999; Im et al., 2000) . Although most of the above situations involve systems in which ETS genes are over-or miss-expressed, they provide an indication that ETS-domain proteins with transactivation activity, could also act as repressors depending on the cell and/ or the promoter context (Roy et al., 1998) . This could be accomplished either by competing with other ETS proteins for speci®c sites or by binding on speci®c promoters and have their activity modulated by other cell type speci®c proteins. Thus the activity of ETS genes should be carefully determined in a context speci®c manner.
Multiple investigators in the ®eld have shown that an isolated ETS DNA-binding domain can act as a transcriptional repressor, and the hypothesis is that it competes for binding with the endogenous ETS-domain proteins. Although this is a plausible hypothesis, it can not be reconciled with the observations that in several cases the observed inhibition by an ETS DNA-binding domain is stronger than the inhibition observed after the mutation or total elimination of the EBS response element on the promoter of the reporter. This would argue for a form of active repression by the isolated ETS DNA-binding domain. Preliminary results from A Sharrock's lab (Univ. of Manchester, UK, personal communication) indicate that the ELK1 DNA-binding domain and possibly other ETS DNAbinding domains may be capable to interact with the Sin3/Histone Deacetylase system. This could explain repression by miss-expressed ETS genes, since in the absence of the correct signals the corresponding proteins could act as repressors. If the ETS domain has an active transcriptional repressor function, would also argue strongly that ETS target genes should be expressed only when dictated by speci®c signals. However, the observed inhibition by the ETS domain could also be due to disturbance in the normal assembly of transcription factor complexes at the promoter or in the exposure of protein domains that do not normally mediate protein ± protein interactions. If these ®ndings are con®rmed for wt ETS proteins expressed at endogenous levels, will change our perception of ETS-domain proteins as transcriptional regulators, in the sense that they not only promote but also permit the transcription of their target genes in a signal dependent manner.
Concluding remarks
Thus far, the identi®ed members of the ETS family with transcriptional repressor activity are either ubiquitous or widely expressed genes, and in all tested cases their activity is regulated by mitogenic signals. Two of these (YAN and ERF) may be involved in cell cycle entry or progression. A third repressor, TEL, may also has a similar function as suggested by by the induced apoptosis observed in TEL7/7 embryos and its alledged tumor suppressor function (Kim et al., 1996) . Finally, a similar role could be envisioned for NET given its role as a TCF, one of the components responsible for immediate transcriptional response to mitogenic stimulation. If such a hypothesis is true it would appear that ETS proteins with transcriptional repression activity may be primarily involved in ensuring the balance between cellular proliferation and dierentiation in dierent cell types and developmental stages, in response to extracellular signals (Figure 2) . From systems like the eects of EGF on Drosophila development, it appears that the same extracellular signals can elicit distinct responses, depending on cell type and developmental stage (for recent reviews see: Young and Wesley, 1997; Schweitzer and Shilo, 1997; Dominguez et al., 1998; Van Buskirk and Schupbach, 1999) . To that extent multiple ETS genes would be required to integrate these signals in dierent cell types to either block or promote cell cycle progression. It is also conceivable that multiple components of the cell cycle machinery are under the transcriptional control of dierent ETS genes, that would be consistent with a distinct and cell type speci®c phenotype associated with each of them. The role of ETS genes in hematopoiesis supports this hypothesis. Today it is largely believed that hematopoietic dierentiation is a stochastic eect (for reviews see Ogawa, 1999; Metcalf, 1999; Busslinger et al., 2000) . Yet over-expression or elimination ETS genes is known to result in phenotypes associated with expansion or elimination of certain cell lineages, arguing for a cell type speci®c survival/proliferative signal provided by these genes (for a review see Spyropoulos, this issue). It is conceivable that this may be a general function of ETS family genes. The fact that most if not all know ETS genes are regulated by extracellular signals, would further argue that they may not be associated with cellular dierentiation. This activity could be expected to be intrinsic to the presence or absence of a given gene in a given cell. However, without the production and careful examination of loss of function mutations, without the identi®cation of ETS target genes and without better understanding of the cell cycle machinery and dierentiation processes, the question of the involvement of the ETS domain proteins in proliferation, dierentiation, both or none, will remain open. 
